WEIGHT LOSS SPECIALIST – DHA LAHORE
Prescription oral tablet combining two appetite-reducing agents for medically supervised weight management in DHA Lahore.
کیوسیمیا دو دوائیوں کا مجموعہ ہے جو بھوک کم کرتی ہے اور وزن میں مستقل کمی لاتی ہے۔ یہ روزانہ ایک بار لی جاتی ہے اور ڈاکٹر رضوان نیازی کی نگرانی میں تجویز کی جاتی ہے۔
Qsymia is a prescription oral tablet that combines two active ingredients: Phentermine and Topiramate. Phentermine suppresses appetite through the central nervous system, while Topiramate reduces food cravings and promotes satiety through a separate neurological pathway.
Clinical trials show average weight loss of 7-10% of body weight over one year, with some patients achieving significantly more when combined with diet and lifestyle changes.
Qsymia uses two complementary mechanisms to reduce food intake and support weight loss.
Acts on the central nervous system to reduce appetite and increase energy expenditure. Helps patients feel less hungry throughout the day.
Works independently to reduce food cravings, improve satiety signals, and support further calorie reduction through a different brain pathway.
Qsymia is FDA-approved for chronic weight management. A thorough clinical assessment is required before it is prescribed.
Dry mouth, constipation, tingling in hands or feet, insomnia, and dizziness are the most commonly reported side effects.
Not suitable during pregnancy, or for patients with glaucoma, hyperthyroidism, or recent MAOI use. A full review is mandatory before starting.
When correctly assessed and monitored by a specialist, Qsymia is well-tolerated and effective for appropriate patients.
Book a consultation with Dr. Rizwan Niazi for a full evaluation and personalised prescription plan.
Dr. Rizwan also prescribes the following oral medications based on individual patient assessment.
ⓘ All medications are prescribed based on individual assessment under proper medical supervision.
Qsymia contains a controlled substance (Phentermine) and requires a full specialist assessment before prescribing. Regular monitoring ensures the medication is working safely and effectively for your case.
Medical history, cardiovascular status, and any contraindications are assessed before a prescription is issued.
Monthly progress checks allow dose adjustments and early identification of any side effects.
Blood pressure, heart rate, and metabolic markers are tracked throughout the course of treatment.
Qsymia, Contrave, Orlistat, and weight loss injections each suit different patient profiles. A consultation with Dr. Rizwan Niazi identifies the safest and most effective option for your goals.
Qsymia is an oral prescription tablet containing Phentermine and Topiramate. Phentermine suppresses appetite through the central nervous system, while Topiramate reduces cravings through a separate brain pathway, producing a combined weight loss effect.
Clinical trials show average weight loss of 7-10% of body weight over one year. Some patients lose more, particularly when Qsymia is combined with dietary changes and regular physical activity.
Qsymia is available as a prescription medication in Pakistan. Dr. Rizwan Niazi prescribes it following a full clinical assessment at his clinic in DHA Lahore. Availability is subject to current stock at time of consultation.
Qsymia is taken once daily in the morning, with or without food. It should not be taken in the evening as it may cause insomnia. The dose is started low and increased gradually based on your response.
Common side effects include dry mouth, constipation, tingling in the hands or feet, dizziness, and difficulty sleeping. Most side effects are mild and improve as the body adjusts to the medication.
Qsymia is not suitable during pregnancy, for patients with glaucoma, hyperthyroidism, or recent use of MAO inhibitors. A full specialist assessment is required to confirm suitability before any prescription is issued.